The company was founded in Parma in 1935 when Giacomo Chiesi, a chemist who dreamed of doing research, bought the Laboratorio Farmaceutico Parmense and embarked on his entrepreneurial adventure.Following the success of Clenil, Chiesi’s interest extended to the anti-inflammatory and pain killer areas and in 1989 the company launched Brexin, a fast-acting anti-inflammatory with good gastric tolerability. Brexin was soon marketed in over 60 countries, certified for the United States market and now has an international patent. Almost ten years after the Brazilian adventure, the Group’s international expansion is very strong, both in the European and non-European countries. Since 1987, Chiesi has opened affiliates in Pakistan, France, Spain, Greece, the United Kingdom, Austria and the Eastern European countries, the United States, Germany, the Maghreb countries, Turkey, Bulgaria, China, and Scandinavia. The Group’s historical products, focussing on the respiratory and cardiovascular therapeutic areas, continue to be well-established, and new products for neonatal diseases, musculoskeletal and vascular disorders have also been launched.